Skip to main content
Clinical Trials/NCT05573113
NCT05573113
Completed
Not Applicable

Comparative Effectiveness Trial of Bowel Ultrasound and Abdominal Radiograph Versus Abdominal Radiograph Alone for Diagnosis of Necrotizing Enterocolitis

Children's Mercy Hospital Kansas City2 sites in 1 country169 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Necrotizing Enterocolitis
Sponsor
Children's Mercy Hospital Kansas City
Enrollment
169
Locations
2
Primary Endpoint
Days to Full Enteral Feeds: Extended Rule Out Group
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The overall objective of our study is to determine the clinical usefulness of BUS for NEC evaluation in diverse NICU settings.

Detailed Description

Bowel ultrasound (BUS) for NEC evaluation is a non-invasive imaging modality that allows real-time assessment of the intestinal wall, vascular perfusion, peristalsis, and abdominal fluid. Advantages of BUS is it is non-invasive, does not have radiation, does not require special preparation before procedure, and is well tolerated even by sick preterm infants. BUS is already being used in centers that have sufficient BUS expertise as an alternative standard of care approach for evaluating NEC, but in a highly variable manner. Standard ultrasound equipment is all that is needed for BUS. Pre-study training will be conducted for sonographers to acquire the study BUS images using standardized technique. Pre-study training of radiologists will also be conducted to standardize the interpretation of BUS findings for NEC. All BUS for NEC ordering, acquisition, and interpretation in the study will be the same as the standard workflow for any other imaging ordered in the clinical setting. All BUS performed as part of the study will not be charged to patients.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
September 18, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Children's Mercy Hospital Kansas City
Responsible Party
Principal Investigator
Principal Investigator

Sherwin Chan MD PhD

Pediatric Radiologist

Children's Mercy Hospital Kansas City

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Days to Full Enteral Feeds: Extended Rule Out Group

Time Frame: Within 30 days of NEC concern

Number of days for infants to tolerate at least 120 mL/kg/day of enteral feeds

Days to Full Enteral Feeds: NEC Ruled In

Time Frame: Within 30 days of NEC concern

Number of days for infants to tolerate at least 120 mL/kg/day of enteral feeds

Days to Full Enteral Feeds: Quick Rule Out Group

Time Frame: Within 30 days of NEC concern

Number of days for infants to tolerate at least 120 mL/kg/day of enteral feeds

Secondary Outcomes

  • Days to End Bowel Rest: Quick Rule Out Group(within 14 days of NEC concern)
  • Days to End Antibiotics: Quick Rule Out(within 14 days of NEC concern)
  • Days to End Antibiotics: NEC Rule In(within 14 days of NEC concern)
  • Days to End Bowel Rest: Extended Rule Out Group(within 14 days of NEC concern)
  • Days to End Bowel Rest: NEC Ruled In(within 14 days of NEC concern)
  • Days to End Antibiotics: Extended Rule Out(within 14 days of NEC concern)

Study Sites (2)

Loading locations...

Similar Trials